Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer
Authors:
- Mahesh P. MoreMMMahesh P. More
- Sagar R. PardeshiSPSagar R. Pardeshi
- Chandrakantsing V. PardeshiCPChandrakantsing V. Pardeshi
- Gaurav A. SonawaneGSGaurav A. Sonawane
- Mahesh N. ShindeMSMahesh N. Shinde
- Prashant K. DeshmukhPDPrashant K. Deshmukh
- Jitendra B. NaikJNJitendra B. Naik
- Abhijeet D. KulkarniAKAbhijeet D. Kulkarni
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Medicine in Drug Discovery
- Vol. 10
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cellsOncotarget, 2015
- Current trends in using polymer coated gold nanoparticles for cancer therapyInternational Journal of Pharmaceutics, 2015
- Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: Synthesis and biological evaluationEuropean Journal of Pharmaceutical Sciences, 2015
- Anticancer potential of medicinal plants and their phytochemicals: a reviewBrazilian Journal of Botany, 2015
- Ameliorative Effect of Fisetin on Cisplatin-Induced Nephrotoxicity in Rats via Modulation of NF-κB Activation and Antioxidant DefencePLOS ONE, 2014
- Reactive Oxygen Species, AMP-activated Protein Kinase, and the Transcription Cofactor p300 Regulate α-Tubulin Acetyltransferase-1 (αTAT-1/MEC-17)-dependent Microtubule Hyperacetylation during Cell StressJournal of Biological Chemistry, 2014
- HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Interactions of Engineered Nanoparticles with Organs Protected by Internal Biological BarriersSmall, 2012
- Gold nanoparticles in cancer therapyActa Pharmacologica Sinica, 2011
- Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-κB-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated IκBα Kinase ActivationMolecular Pharmacology, 2007